How CAR T-Cell Therapy Impacts Relapsed/Refractory MM Treatment

EP: 1.The Rationale for CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma

EP: 2.The Impact of CAR T-Cell Therapy on Relapsed/Refractory MM Treatment

Now Viewing

EP: 3.How CAR T-Cell Therapy Impacts Relapsed/Refractory MM Treatment

EP: 4.Key Takeaways from the CARTITUDE-1 and KarMMa Studies

EP: 5.CAR T-Cell Therapy in R/R MM: Treatment Selection, Safety, and Future Perspectives

EP: 6.Insights from CARTITUDE-4 and KarMMa-3 in R/R MM

EP: 7.Future Perspectives on CAR T-Cell Therapy in Relapsed/Refractory MM

Video content above is prompted by the following questions:

• What is the impact of CAR T-cell therapy on patient quality of life and how does it compare to other available treatments?
  • How do patients typically respond to CAR T-cell therapy in terms of their overall well-being and ability to perform daily activities?
  • Are there any long-term quality of life benefits or challenges associated with CAR T-cell therapy?